These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6471820)

  • 21. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry.
    Fitzgerald RL; Rexin DA; Herold DA
    Clin Chem; 1994 Mar; 40(3):373-80. PubMed ID: 8131270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Method comparison of EMIT 700 and EMIT II with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Anal Toxicol; 1994; 18(2):110-7. PubMed ID: 8207931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
    Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
    J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
    Huestis MA; Mitchell JM; Cone EJ
    Clin Chem; 1994 May; 40(5):729-33. PubMed ID: 8174244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine.
    Kovatsi L; Pouliopoulos A; Papadaki A; Samanidou V; Tsoukali H
    J Anal Toxicol; 2010 May; 34(4):229-32. PubMed ID: 20465870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A; Poklis JL; Tarnai LD; Backer RC
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The detection and quantification of cannabinoids in blood and urine by RIA, HPLC/RIA and GC/MS.
    Law B; Williams PL; Moffat AC
    Vet Hum Toxicol; 1979; 21 Suppl():144-7. PubMed ID: 505941
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the online immunoassay for propoxyphene: comparison to EMIT II and GC-MS.
    McNally AJ; Pilcher I; Wu R; Salamone SJ; Brewington S; King JW; Irving J
    J Anal Toxicol; 1996; 20(7):537-40. PubMed ID: 8934302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA; Schwarzhoff RH; Hubster EC; Liserio MK
    Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines.
    Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG
    Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cocaine, amphetamines and cannabis use in university students through hair analysis: preliminary results.
    Quintela O; Bermejo AM; Tabernero MJ; Strano-Rossi S; Chiarotti M; Lucas AC
    Forensic Sci Int; 2000 Jan; 107(1-3):273-9. PubMed ID: 10689579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of phenytoin in plasma: a comparison of procedures using a new radioimmunoassay, gas chromatography, and enzyme immunoassay.
    Stanley PE; Peikert MR
    Epilepsia; 1978 Jun; 19(3):265-72. PubMed ID: 354921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a radioimmunoassay (125I) kit for cannabinoid metabolites in urine and whole blood.
    Childs PS; McCurdy HH
    J Anal Toxicol; 1984; 8(5):220-3. PubMed ID: 6503225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Method comparison of EMIT II and online with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Forensic Sci; 1993 Nov; 38(6):1326-41. PubMed ID: 8263477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.